register

News & Trends - Biotechnology

New partnership to advance genomic research in Australasia

Health Industry Hub | July 3, 2024 |

Biotech News: The Australian Genome Research Facility (AGRF) has entered a strategic partnership with US-based Dovetail Genomics.

As Australia’s non-profit genomic sequencing service provider, AGRF powers genomics through a national network of services and expertise. This collaboration is aimed at bolstering genomic research and innovation across Australia and New Zealand, launching AGRF as the premier provider of Dovetail’s cutting-edge products and services in the Australasian market.

Under this partnership, AGRF will offer Dovetail’s comprehensive 3D genomic portfolio of proximity ligation-based products, including Dovetail Omni-C, Micro-C, and the new family of LinkPrep Technology based products, TopoLink, AssemblyLink, and VariLink Kits. By integrating Dovetail’s proprietary technologies, AGRF will provide localised, high-quality genomic services, transforming the way researchers study the 3D genome.

This alliance not only redefines the accessibility and application of advanced genomics across various sectors, including biomedical, agri-genomics, and clinical research, but it also significantly enhances and expands AGRF’s service offerings.

Dr Mathew Easterday, CEO of Dovetail Genomics, shared his enthusiasm for the new strategic partnership, stating, “Our collaboration with AGRF is not just a partnership; it’s a powerful union that combines Dovetail’s cutting-edge technological platforms with AGRF’s extensive and robust service network to unlock new research opportunities in Australasia.

“Together, we are committed to advancing genomic research and setting new benchmarks for what can be achieved in the realms of biomedical, agricultural, and clinical research.”

The collaboration aligns with global industry trends as Hi-C technologies gain traction across a plethora of genomic applications and disease states.

Dr Cath Moore, Chief Scientific Officer at AGRF, elaborated on the significance of the partnership, stating, “3D genomics is transformative for researchers utilising AGRF’s genomic services. Unlocking the spatial mysteries of DNA; how it folds and loops and how that impacts gene regulation, cell differentiation, genome stability, and disease mechanisms.

“Bringing this capability to AGRF, and so to the Australian research community, provides a comprehensive understanding of genome function beyond linear DNA sequences, transforming our knowledge of cellular biology and disease mechanisms.”

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - MedTech & Diagnostics

APAC medtech company scores TGA approval in heart disease

APAC medtech company scores TGA approval in heart disease

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics News: An Asia Pacific medtech company has announced that its flagship drug-eluting stent (DES) has received regulatory […]

More


News & Trends - MedTech & Diagnostics

New state-based pilot to back home-grown medtech innovation

New state-based pilot to back home-grown medtech innovation

Health Industry Hub | October 4, 2024 |

MedTech & Diagnostics: In a bid to enhance opportunities for local medtech manufacturers to sell to health services, a connected […]

More


News & Trends - Pharmaceuticals

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Ferring unveils first real-world evidence for faecal calprotectin approach in ulcerative colitis

Health Industry Hub | October 4, 2024 |

Pharma News: Ferring Pharmaceuticals has announced results from a new study, which provides the first real-world evidence supporting the efficacy […]

More


News & Trends - Pharmaceuticals

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Bayer partners with RACGP, calls for MBS reforms to boost access to long-acting contraceptives

Health Industry Hub | October 4, 2024 |

Pharma News: Australian women are calling for more accurate information about their contraceptive options, with 70% feeling inadequately educated about […]

More


This content is copyright protected. Please subscribe to gain access.